Back to News
Market Impact: 0.25
Emboline Announces First U.S. Commercial Use of the Emboliner® Embolic Protection System
Source: PR Newswire
Healthcare & BiotechProduct LaunchesRegulation & LegislationTechnology & Innovation
Emboline announced the first commercial use of its next-generation embolic protection technology, marking the start of U.S. commercialization after receiving FDA 510(k) clearance. The milestone validates the company’s regulatory pathway and moves the medical-device product from clearance into initial commercial deployment, though no revenue, procedure-volume, or financial guidance was disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.48
More News
- Mark Ruffalo says Paramount’s $111 billion Warner Bros. deal ‘Will stifle creativity, weaken free speech, and cost people their jobs’
- States, cities sue U.S. agencies over weaker vehicle fuel economy rules
- Anthropic warns government attitudes may hurt customer ties, IPO prospectus shows: Reuters
- Paramount and Warner Bros Discovery to become Skydance
- FAA says Boeing 737 Max software glitch not a flight-safety issue
- Paramount’s Warner Bros. megamerger will just be called Skydance